Carboplatin - Generic Drug Details

See Plans and Pricing

« Back to Dashboard

What are the generic sources for carboplatin and what is the scope of freedom to operate?

Carboplatin is the generic ingredient in two branded drugs marketed by Cipla Ltd, Fresenius Kabi Usa, Hospira, Mylan Labs Ltd, Pliva, Sandoz, Watson Labs Teva, West-ward Pharms Int, Corden Pharma, Accord Hlthcare, Actavis Totowa, Akorn, Eugia Pharma, Gland Pharma Ltd, Hong Kong, Ingenus Pharms Llc, Mylan Institutional, Pharmachemie Bv, Pliva Lachema, Sandoz Inc, Sun Pharm, Teva Parenteral, Teva Pharms Usa, and Cordenpharma, and is included in thirty-five NDAs. Additional information is available in the individual branded drug profile pages.

There are eighteen drug master file entries for carboplatin. Ten suppliers are listed for this compound. There is one tentative approval for this compound.

Summary for carboplatin

US Patents:	0
Tradenames:	2
Applicants:	24
NDAs:	35
Drug Master File Entries:	18
Suppliers / Packagers:	10
Bulk Api Vendors:	96
Clinical Trials:	2,185
Patent Applications:	181
Formulation / Manufacturing:	see details
Drug Prices:	Drug price trends for carboplatin
DailyMed Link:	carboplatin at DailyMed

See drug prices for carboplatin

Recent Clinical Trials for carboplatin

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Guangzhou Institute of Respiratory Disease	Phase 2
Incyte Corporation	Phase 2
Jiangsu Alphamab Biopharmaceuticals Co., Ltd	Phase 2

See all carboplatin clinical trials

Generic filers with tentative approvals for CARBOPLATIN

Applicant	Application No.	Strength	Dosage Form
See Pricing	See Pricing	450MG/VIAL	INJECTABLE;INJECTION
See Pricing	See Pricing	150MG/VIAL	INJECTABLE;INJECTION
See Pricing	See Pricing	50MG/VIAL	INJECTABLE;INJECTION

The 'tentative' approval signifies that the product meets all FDA standards for marketing, and, but for the patents / regulatory protections, it would approved.

Pharmacology for carboplatin

Drug Class	Platinum-based Drug

Medical Subject Heading (MeSH) Categories for carboplatin

Antineoplastic Agents
Cross-Linking Reagents

Synonyms for carboplatin

(SP-4-2)-Diamimine[1,1-cyclobutanedi(carboxylato-kO)(2-)]platinum
(SP-4-2)-diammine[cyclobutane-1,1-dicarboxylato(2-)-kappa(2)O,O']platinum
1,1-Cyclobutanedicarboxylate
1,1-Cyclobutanedicarboxylate diammine platinum(II)
1,1-CYCLOBUTANEDICARBOXYLATODIAMMINE PLATINUM
1,1-Cyclobutanedicarboxylatodiammineplatinum (II)
1,1-Cyclobutanedicarboxylatodiammineplatinum(II)
10329-EP2269988A2
10329-EP2269989A1
10329-EP2270008A1
10329-EP2272827A1
10329-EP2275102A1
10329-EP2275412A1
10329-EP2275413A1
10329-EP2275420A1
10329-EP2277876A1
10329-EP2280012A2
10329-EP2281815A1
10329-EP2287156A1
10329-EP2292233A2
10329-EP2292614A1
10329-EP2292615A1
10329-EP2292617A1
10329-EP2295055A2
10329-EP2295416A2
10329-EP2295426A1
10329-EP2295427A1
10329-EP2298748A2
10329-EP2298764A1
10329-EP2298765A1
10329-EP2298768A1
10329-EP2298772A1
10329-EP2298778A1
10329-EP2301536A1
10329-EP2301538A1
10329-EP2301928A1
10329-EP2301933A1
10329-EP2305243A1
10329-EP2305640A2
10329-EP2305642A2
10329-EP2305671A1
10329-EP2308812A2
10329-EP2308833A2
10329-EP2308839A1
10329-EP2308855A1
10329-EP2308861A1
10329-EP2311453A1
10329-EP2311455A1
10329-EP2311807A1
10329-EP2311808A1
10329-EP2311825A1
10329-EP2311827A1
10329-EP2311829A1
10329-EP2311840A1
10329-EP2314590A1
10329-EP2316452A1
10329-EP2316831A1
10329-EP2316832A1
10329-EP2316833A1
10329-EP2316834A1
10329-EP2374454A1
41575-94-4
575C944
6,8-dioxa-7-platinaspiro[3.5]nonane-5,9-dione
6,8-dioxa-7-platinaspiro[3.5]nonane-5,9-dione diamine
7,7-diamino-[?]spiro[3.5]nonane-5,9-dione
7,7-dimethyl-6,8-dioxa-7$l^{4}-platinaspiro[3.5]nonane-5,9-dione
70903-55-8
AB0013326
AB01273939-01
AB01274771_03
AB01274771-01
AB01274771-02
AB01568249_01
AC-1457
AC1NR9YB
AKOS015905301
AKOS022185820
AKOS024457202
AOB5507
AS-13313
BC204693
BCP22717
BDBM50274681
BDBM92389
BG3F62OND5
BRD-K11626735-318-02-0
BSPBio_003145
C 2538
C-21145
C6H10N2O4Pt
C6H6O4Pt.2NH3
Carbopaltin
Carboplatin ,(S)
Carboplatin (JP17/USP/INN)
Carboplatin (USAN)
Carboplatin [USAN:INN:BAN:JAN]
Carboplatin [USAN:USP:INN:BAN:JAN]
Carboplatin, British Pharmacopoeia (BP) Reference Standard
Carboplatin, United States Pharmacopeia (USP) Reference Standard
Carboplatine
Carboplatine [French]
Carboplatino
Carboplatino [Spanish]
Carboplatinum
Carboplatinum [Latin]
Caronplatin, 4
CAS-41575-94-4
Cbdca
cbdca(2-)
CCG-204325
CCG-39887
CCRIS 3404
CHEBI:31355
CHEBI:35690
cis -Diammine[1,1-cyclobutane-dicarboxylato] platinum
cis-(1,1-Cyclobutanedicarboxylato)diammineplatinum(II)
cis-Diamine[1,1-cyclobutanedicarboxylato]platinum(II)
cis-Diammine(1,1-cyclobutanedicarboxylato) platinum
cis-Diammine(1,1-cyclobutanedicarboxylato)platinum
cis-Diammine(1,1-cyclobutanedicarboxylato)platinum(II)
cis-Diammine(cyclobutanedicarboxylato)platinum II
cis-Diammine[1,1-cyclobutane-dicarboxylato] platinum
cis-diamminecyclobutanedicarboxylatoplatinum(II);
CS-1121
cyclobutane dicarboxylate platinum (ii)
cyclobutane-1,1-dicarboxylate
cyclobutane-1,1-dicarboxylate(2-)
D01363
DB00958
diamino[cyclobutane-1,1-dicarboxylato(2-)-kappa~2~O~1~,O~1~]platinum
Diammine-1,1-cyclobutane dicarboxylate platinum II
Diammine(1,1-cyclobutanedicarboxylato)platinum (II)
Diammine(cyclobutane-1,1-dicarboxylato(2-)-O,O')platinum
diammine[cyclobutane-1,1-dicarboxylato(2-)-k2O1,O1]platinum
DivK1c_000892
DSSTox_CID_26742
DSSTox_GSID_46742
DSSTox_RID_81870
DTXSID3046742
EBD50809
EINECS 255-446-0
Epitope ID:194801
Ercar
EU-0100230
FT-0602925
H876
HMS1921J16
HMS2090M05
HMS2092B22
HMS3260N21
HMS3269H03
HMS502M14
HSDB 6957
HY-17393
I14-2390
IDI1_000892
JM 8
JM-8
K-8751
KBio1_000892
KBio2_002009
KBio2_004577
KBio2_007145
KBio3_002645
KBioGR_000713
KBioSS_002009
Lopac-C-2538
Lopac0_000230
LP00230
LS-117689
MFCD00070464
MFCD00070464 (98+%)
MolPort-003-845-609
MolPort-006-147-683
MolPort-035-395-692
NCGC00015223-01
NCGC00015223-02
NCGC00015223-03
NCGC00015223-04
NCGC00015223-05
NCGC00015223-06
NCGC00015223-07
NCGC00015223-08
NCGC00015223-09
NCGC00015223-10
NCGC00093695-01
NCGC00094961-01
NCGC00094961-02
NCGC00094961-03
NCGC00162099-01
NCGC00162099-02
NCGC00167800-01
NCGC00178242-01
NCGC00260915-01
NCGC00263858-02
NCGC00263858-03
NINDS_000892
NSC 201345
NSC 241240
NSC-201345
NSC-241240
NSC-758182
NSC201345
NSC241240
NSC758182
OLESAACUTLOWQZ-UHFFFAOYSA-L
Paraplatin
Paraplatin (Bristol Meyers)
Paraplatin (TN)
Paraplatin-AQ
Pharmakon1600-01502106
Platinum, {diammine[1,1-cyclobutanedicarboxylato(2-)-O,O']-,} (SP-4-2)-
Platinum, diamine(1, 1-cyclobutanedicarboxylato(2-)-O,O')-, (SP-4-2)-
Platinum, diammine(1,1-cyclobutanedi(carboxylato-kappaO)(2-))-, (SP-4-2)-
Platinum, diammine(1,1-cyclobutanedicarboxylato(2-)-O,O')-, (SP-4-2)
Platinum, diammine(1,1-cyclobutanedicarboxylato(2-)-O,O')-, (SP-4-2)-
Platinum, diammine(1,1-cyclobutanedicarboxylato(2-))-, (SP-4-2)-
Platinum, diammine[1,1-cyclobutanedicarboxylato(2-)-.kappa.O,.kappa.O'']-, (SP-4-2)-
Platinum, diammine[1,1-cyclobutanedicarboxylato(2-)-O,O']-, (SP-4-2)-
Platinum,1-cyclobutanedicarboxylato(2-)-O,O')-, (SP-4-2)-
Platinum,1-cyclobutanedicarboxylato(2-)-O,O']-, (SP-4-2)-
Platinum(II), (1, 1-cyclobutanedicarboxylato)diammine-, cis-
Platinum(II), (1,1-cyclobutanedicarboxylato)diammine-, cis-
Platinum(II),1-cyclobutanedicarboxylato)diammine-, cis-
RL03611
s1215
SBI-0050218.P002
SC-18620
SCHEMBL4964
SPBio_000716
Spectrum_001529
SPECTRUM1502106
Spectrum2_000898
Spectrum3_001503
Spectrum4_000337
Spectrum5_001094
SR-01000076253
SR-01000076253-1
SR-01000076253-5
SR-05000002039
SR-05000002039-1
ST24046284
STL451040
SY075575
Tox21_112586
Tox21_112586_1
Tox21_500230
UNII-BG3F62OND5
W-106301
ZB013490

US Patents and Regulatory Information for carboplatin

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or request a copy of the full page.
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Hong Kong	CARBOPLATIN	carboplatin	INJECTABLE;INTRAVENOUS	077096-004	Jun 3, 2013	AP	RX	No	No	See Pricing	See Pricing				See Pricing
Ingenus Pharms Llc	CARBOPLATIN	carboplatin	INJECTABLE;INTRAVENOUS	208487-003	Apr 26, 2017	AP	RX	No	No	See Pricing	See Pricing				See Pricing
Sandoz Inc	CARBOPLATIN	carboplatin	INJECTABLE;INTRAVENOUS	078280-001	May 8, 2008	AP	RX	No	No	See Pricing	See Pricing				See Pricing
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for carboplatin

Subscribe to access the full database, or request a copy of the full page.
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Cordenpharma	PARAPLATIN	carboplatin	INJECTABLE;INTRAVENOUS	020452-002	Jul 14, 2003	See Pricing	See Pricing
Corden Pharma	PARAPLATIN	carboplatin	INJECTABLE;INJECTION	019880-001	Mar 3, 1989	See Pricing	See Pricing
Corden Pharma	PARAPLATIN	carboplatin	INJECTABLE;INJECTION	019880-003	Mar 3, 1989	See Pricing	See Pricing
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.